Cesca Therapeutics, Inc. (KOOL) Starts Presentation at Annual Marcum MicroCap Conference

Cesca Therapeutics, Inc. (NASDAQ: KOOL) is engaged in the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine. The company’s automated blood and bone marrow processing systems enable the separation, processing and preservation of cell and tissue therapy products. Its current portfolio includes the SurgWerks™ Platform, AXP^(R) AutoXpress^(R) Platform (AXP), the MarrowXpress Platform (MXP), the Res-Q™ 60 (Res-Q) point-of-care system, and the BioArchive^(R) System. For more information, visit the company’s website at www.cescatherapeutics.com